Our results showed that first, compared with positive control TNF-α, IκB-α phosphorylation could not be detected in HCC cells after treatment with Lexa, suggesting that specific binding to DR5 avoids activation of the NF-κB signaling pathway in HCC cells. The gene discussed is TNFRSF10B; the disease is hepatocellular carcinoma.